Several sclerosis and cancer cells therapies have actually driven development in Merck’s life scientific research company, yet the business downgrades its full-year earnings projection, currently targeting development of approximately 2-7%.
发布者:BY ULRICH QUISTGAARD,转转请注明出处:https://robotalks.cn/merck-downgrades-earnings-guidance-due-to-geopolitical-turmoil-2/